BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16029420)

  • 21. Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf.
    Jiao Z; Mollaaghababa R; Pavan WJ; Antonellis A; Green ED; Hornyak TJ
    Pigment Cell Res; 2004 Aug; 17(4):352-62. PubMed ID: 15250937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation.
    Neyret-Kahn H; Benhamed M; Ye T; Le Gras S; Cossec JC; Lapaquette P; Bischof O; Ouspenskaia M; Dasso M; Seeler J; Davidson I; Dejean A
    Genome Res; 2013 Oct; 23(10):1563-79. PubMed ID: 23893515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of SUMO E2 conjugation enzyme: differential expression profile in Schistosoma mansoni.
    Pereira RV; Cabral FJ; Gomes MS; Baba EH; Jannotti-Passos LK; Carvalho O; Rodrigues V; Afonso RJ; Castro-Borges W; Guerra-Sá R
    Parasitol Res; 2011 Dec; 109(6):1537-46. PubMed ID: 21573813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMOylation modulates transcriptional repression by TRPS1.
    Kaiser FJ; Lüdecke HJ; Weger S
    Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
    Bojović BB; Hassell JA
    DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular signal-regulated kinase mitogen-activated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3.
    Guo B; Sharrocks AD
    Mol Cell Biol; 2009 Jun; 29(11):3204-18. PubMed ID: 19307308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment.
    Mohan RD; Rao A; Gagliardi J; Tini M
    Mol Cell Biol; 2007 Jan; 27(1):229-43. PubMed ID: 17060459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.
    Fradet-Turcotte A; Brault K; Titolo S; Howley PM; Archambault J
    Virology; 2009 Dec; 395(2):190-201. PubMed ID: 19836047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of SOX6 transcriptional activity by SUMO modification.
    Fernández-Lloris R; Osses N; Jaffray E; Shen LN; Vaughan OA; Girwood D; Bartrons R; Rosa JL; Hay RT; Ventura F
    FEBS Lett; 2006 Feb; 580(5):1215-21. PubMed ID: 16442531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
    Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
    Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of DNA binding by differential sumoylation of heat shock factors.
    Anckar J; Hietakangas V; Denessiouk K; Thiele DJ; Johnson MS; Sistonen L
    Mol Cell Biol; 2006 Feb; 26(3):955-64. PubMed ID: 16428449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
    Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
    Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
    Sestáková B; Ondrusová L; Vachtenheim J
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUMOylation negatively regulates transcriptional and oncogenic activities of MafA.
    Kanai K; Reza HM; Kamitani A; Hamazaki Y; Han SI; Yasuda K; Kataoka K
    Genes Cells; 2010 Sep; 15(9):971-82. PubMed ID: 20718938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
    Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
    Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).
    Sánchez-Álvarez M; Montes M; Sánchez-Hernández N; Hernández-Munain C; Suñé C
    J Biol Chem; 2010 May; 285(20):15220-15233. PubMed ID: 20215116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9.
    Xu W; Gong L; Haddad MM; Bischof O; Campisi J; Yeh ET; Medrano EE
    Exp Cell Res; 2000 Mar; 255(2):135-43. PubMed ID: 10694430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of enzymes involved in SUMOylation in Trypanosoma brucei.
    Ye K; Zhang X; Ni J; Liao S; Tu X
    Sci Rep; 2015 May; 5():10097. PubMed ID: 25959766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Starting and stopping SUMOylation. What regulates the regulator?
    Watts FZ
    Chromosoma; 2013 Dec; 122(6):451-63. PubMed ID: 23812602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.